Impact of a Pharmacist-Led Intervention on 30-Day Readmission and Assessment of Factors Predictive of Readmission in African American Men With Heart Failure
- PMID: 30486711
- PMCID: PMC6775676
- DOI: 10.1177/1557988318814295
Impact of a Pharmacist-Led Intervention on 30-Day Readmission and Assessment of Factors Predictive of Readmission in African American Men With Heart Failure
Abstract
Heart failure (HF) is responsible for more 30-day readmissions than any other condition. Minorities, particularly African American males (AAM), are at much higher risk for readmission than the general population. In this study, demographic, social, and clinical data were collected from the electronic medical records of 132 AAM patients (control and intervention) admitted with a primary or secondary admission diagnosis of HF. Both groups received guideline-directed therapy for HF. Additionally the intervention group received a pharmacist-led intervention. Data collected from these patients were used to develop and validate a predictive model to evaluate the impact of the pharmacist-led intervention, and identify predictors of readmission in this population. After propensity score matching, the intervention was determined to have a significant impact on readmission, as a significantly smaller proportion of patients in the intervention group were readmitted as compared to the control group (11.5% vs. 42.9%; p = .03). A predictive model for 30-day readmission was developed using K-nearest neighbor (KNN) classification algorithm. The model was able to correctly classify about 71% patients with an AUROC of 0.70. Additionally, the model provided a set of key patient attributes predictive of readmission status. Among these predictive attributes was whether or not a patient received the intervention. A relative risk analysis identified that patients who received the intervention are less likely to be readmitted within 30 days. This study demonstrated the benefit of a pharmacist-led intervention for AAM with HF. Such interventions have the potential to improve quality of life for this patient population.
Keywords: heart failure; machine learning; pharmacist intervention; predictive modeling; readmission.
Conflict of interest statement
Figures



Similar articles
-
PREDICTIVE MODELING OF HOSPITAL READMISSION RATES USING ELECTRONIC MEDICAL RECORD-WIDE MACHINE LEARNING: A CASE-STUDY USING MOUNT SINAI HEART FAILURE COHORT.Pac Symp Biocomput. 2017;22:276-287. doi: 10.1142/9789813207813_0027. Pac Symp Biocomput. 2017. PMID: 27896982 Free PMC article.
-
Early Unplanned Readmissions After Admission to Hospital With Heart Failure.Am J Cardiol. 2019 Sep 1;124(5):736-745. doi: 10.1016/j.amjcard.2019.05.053. Epub 2019 Jun 6. Am J Cardiol. 2019. PMID: 31300202
-
Validation of the Readmission Risk Score in Heart Failure Patients at a Tertiary Hospital.J Card Fail. 2015 Nov;21(11):885-91. doi: 10.1016/j.cardfail.2015.07.010. Epub 2015 Jul 21. J Card Fail. 2015. PMID: 26209002
-
Implementation of a Patient Navigator Program to Reduce 30-day Heart Failure Readmission Rate.Prog Cardiovasc Dis. 2017 Sep-Oct;60(2):259-266. doi: 10.1016/j.pcad.2017.07.004. Epub 2017 Jul 22. Prog Cardiovasc Dis. 2017. PMID: 28743529 Review.
-
Systematic Review and Meta-analysis of Pharmacist-Led Transitions of Care Services on the 30-Day All-Cause Readmission Rate of Patients with Congestive Heart Failure.Clin Drug Investig. 2019 Aug;39(8):703-712. doi: 10.1007/s40261-019-00797-2. Clin Drug Investig. 2019. PMID: 31102109
Cited by
-
The Impact of Pharmacist-Based Services Across the Spectrum of Outpatient Heart Failure Therapy.Curr Treat Options Cardiovasc Med. 2019 Sep 10;21(10):59. doi: 10.1007/s11936-019-0750-3. Curr Treat Options Cardiovasc Med. 2019. PMID: 31506885 Review.
-
Increased social deprivation index scores are associated with 180-day readmissions, but not index admissions, for acute heart failure.PLoS One. 2025 Jul 3;20(7):e0327123. doi: 10.1371/journal.pone.0327123. eCollection 2025. PLoS One. 2025. PMID: 40608699 Free PMC article.
-
Multidimensional Interventions on Supporting Disease Management for Hospitalized Patients with Heart Failure: The Role of Clinical and Community Pharmacists.J Clin Med. 2023 Apr 21;12(8):3037. doi: 10.3390/jcm12083037. J Clin Med. 2023. PMID: 37109373 Free PMC article. Review.
-
Optimizing Medical Therapy in Chronic Worsening HFrEF: A Long Way to Go.J Am Coll Cardiol. 2019 Mar 5;73(8):945-947. doi: 10.1016/j.jacc.2018.12.027. J Am Coll Cardiol. 2019. PMID: 30819363 Free PMC article. No abstract available.
-
Machine learning vs. conventional statistical models for predicting heart failure readmission and mortality.ESC Heart Fail. 2021 Feb;8(1):106-115. doi: 10.1002/ehf2.13073. Epub 2020 Nov 17. ESC Heart Fail. 2021. PMID: 33205591 Free PMC article.
References
-
- Bahrami H., Kronmal R., Bluemke D. A., Olson J., Shea S., Liu K., … Lima J. A. (2008). Differences in the incidence of congestive heart failure by ethnicity: The multi-ethnic study of atherosclerosis. Archives of Internal Medicine, 168(19), 2138–2145. doi:10.1001/archinte.168.19.2138 - DOI - PMC - PubMed
-
- Chang P. P., Chambless L. E., Shahar E., Bertoni A. G., Russell S. D., Ni H. Y., … Rosamond W. D. (2014). Incidence and survival of hospitalized acute decompensated heart failure in four US communities (from the atherosclerosis risk in communities study). American Journal of Cardiology, 113(3), 504–510. doi:10.1016/j.amjcard.2013.10.032 - DOI - PMC - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous